Biotechnology > Eli Lilly and Company
Tracking since May 20, 2026 · Latest signal Apr 20, 2026 · 3 matched data points
Overall sentiment
Positive 100% (3)Negative 0% (0)Neutral 0% (0)
Daily sentiment
Claims (1)
Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.
Parent: BiotechnologyEntity: Eli Lilly and CompanySub-entity: Acquisition of Kelonia TherapeuticsImpact: positiveDate: Apr 20, 2026Target: Eli Lilly and Company's acquisition of Kelonia Therapeutics3 matched entries3 confirmed0 disputed0 neutral0 unclear